Search research articles
Contact Us
Filters
Showing results (101-110 of 138) with videos related to
Page
of 14
Sort By:
Cancer Treatment Reviews
|
March 17, 2021
Knowns and unknowns of bone metastases in patients with neuroendocrine neoplasms: A systematic review and meta-analysis
Esmeralda Garcia-Torralba, Francesca Spada, Kok Haw Jonathan Lim, et al.
Endocrine-Related Cancer
|
November 6, 2010
The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients
Susanna Leskelä, Luis J Leandro-García, Marta Mendiola, et al.
Journal of the National Cancer Institute
|
January 29, 2017
Design and Validation of the GI-NEC Score to Prognosticate Overall Survival in Patients With High-Grade Gastrointestinal Neuroendocrine Carcinomas
Angela Lamarca, Thomas Walter, Marianne Pavel, et al.
Clinical Colorectal Cancer
|
January 1, 2021
The Impact of Changes in Service Delivery in Patients With Colorectal Cancer During the Initial Phase of the COVID-19 Pandemic
Konstantinos Kamposioras, Mark Saunders, Kok Haw Jonathan Lim, et al.
World Journal of Gastroenterology
|
June 1, 2022
Management of incidentally discovered appendiceal neuroendocrine tumors after an appendicectomy
José Luis Muñoz de Nova, Jorge Hernando, Miguel Sampedro Núñez, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 30, 2010
A study of the pattern of hospital admissions in a specialist Phase I oncology trials unit: unplanned admissions as an early indicator of patient attrition
Andre T Brunetto, Joo Ern Ang, David Olmos, et al.
British Journal of Cancer
|
June 9, 2026
Body mass index, adjuvant chemotherapy, toxicity, and survival in non-metastatic colorectal cancer: an individual participant data meta-analysis (OCTOPUS)
Corinna G V Slawinski, Lee Malcomson, Jorge Barriuso, et al.
Cancers
|
May 16, 2023
Prospective Observational Study of Prevalence, Assessment and Treatment of Pancreatic Exocrine Insufficiency in Patients with Inoperable Pancreatic Malignancy (PANcreatic Cancer Dietary Assessment-PanDA)
Lindsay E Carnie, Dinakshi Shah, Kate Vaughan, et al.
British Journal of Cancer
|
January 26, 2019
Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomal formulation in patients with solid tumours
T R Jeffry Evans, Emma Dean, L Rhoda Molife, et al.
Plos One
|
December 19, 2009
KRAS mutations in primary colorectal cancer tumors and related metastases: a potential role in prediction of lung metastasis
Paloma Cejas, Miriam López-Gómez, Cristina Aguayo, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 138) with videos related to
Sort By:
Page
of 14
Cancer Treatment Reviews
|
March 17, 2021
Knowns and unknowns of bone metastases in patients with neuroendocrine neoplasms: A systematic review and meta-analysis
Esmeralda Garcia-Torralba, Francesca Spada, Kok Haw Jonathan Lim, et al.
Endocrine-Related Cancer
|
November 6, 2010
The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients
Susanna Leskelä, Luis J Leandro-García, Marta Mendiola, et al.
Journal of the National Cancer Institute
|
January 29, 2017
Design and Validation of the GI-NEC Score to Prognosticate Overall Survival in Patients With High-Grade Gastrointestinal Neuroendocrine Carcinomas
Angela Lamarca, Thomas Walter, Marianne Pavel, et al.
Clinical Colorectal Cancer
|
January 1, 2021
The Impact of Changes in Service Delivery in Patients With Colorectal Cancer During the Initial Phase of the COVID-19 Pandemic
Konstantinos Kamposioras, Mark Saunders, Kok Haw Jonathan Lim, et al.
World Journal of Gastroenterology
|
June 1, 2022
Management of incidentally discovered appendiceal neuroendocrine tumors after an appendicectomy
José Luis Muñoz de Nova, Jorge Hernando, Miguel Sampedro Núñez, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 30, 2010
A study of the pattern of hospital admissions in a specialist Phase I oncology trials unit: unplanned admissions as an early indicator of patient attrition
Andre T Brunetto, Joo Ern Ang, David Olmos, et al.
British Journal of Cancer
|
June 9, 2026
Body mass index, adjuvant chemotherapy, toxicity, and survival in non-metastatic colorectal cancer: an individual participant data meta-analysis (OCTOPUS)
Corinna G V Slawinski, Lee Malcomson, Jorge Barriuso, et al.
Cancers
|
May 16, 2023
Prospective Observational Study of Prevalence, Assessment and Treatment of Pancreatic Exocrine Insufficiency in Patients with Inoperable Pancreatic Malignancy (PANcreatic Cancer Dietary Assessment-PanDA)
Lindsay E Carnie, Dinakshi Shah, Kate Vaughan, et al.
British Journal of Cancer
|
January 26, 2019
Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomal formulation in patients with solid tumours
T R Jeffry Evans, Emma Dean, L Rhoda Molife, et al.
Plos One
|
December 19, 2009
KRAS mutations in primary colorectal cancer tumors and related metastases: a potential role in prediction of lung metastasis
Paloma Cejas, Miriam López-Gómez, Cristina Aguayo, et al.
Page
of 14